Stay updated on CTII-nCoV Vaccine: Phase II Clinical Trial
Sign up to get notified when there's something new on the CTII-nCoV Vaccine: Phase II Clinical Trial page.

Latest updates to the CTII-nCoV Vaccine: Phase II Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new Locations section appears with Hubei as a study location, and the separate Hubei Locations entry and the HHS Vulnerability Disclosure link have been removed. The page revision is updated to v3.3.3.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedMinor editorial updates: added a PubMed auto-fill explanatory note and updated the revision to v3.3.2, while the older PubMed note and revision v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding/operational status notice banner was removed; core study content and navigation remain unchanged.SummaryDifference0.4%

- Check62 days agoChange DetectedThe two screenshots depict the same study record with no changes to core content; only cosmetic layout differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference4%

- Check98 days agoChange DetectedAdds version v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) plus an older version tag (v3.0.2).SummaryDifference0.5%

Stay in the know with updates to CTII-nCoV Vaccine: Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTII-nCoV Vaccine: Phase II Clinical Trial page.